Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $11.95 million. The enterprise value is $18.04 million.
| Market Cap | 11.95M |
| Enterprise Value | 18.04M |
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.97 million shares outstanding. The number of shares has decreased by -8.42% in one year.
| Current Share Class | 1.97M |
| Shares Outstanding | 1.97M |
| Shares Change (YoY) | -8.42% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 3.70% |
| Owned by Institutions (%) | 0.68% |
| Float | 2.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 23 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.64% in the last 52 weeks. The beta is 0.82, so BOLT's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +29.64% |
| 50-Day Moving Average | 4.63 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 58.40 |
| Average Volume (20 Days) | 747,333 |
Short Selling Information
The latest short interest is 15,751, so 0.80% of the outstanding shares have been sold short.
| Short Interest | 15,751 |
| Short Previous Month | 25,736 |
| Short % of Shares Out | 0.80% |
| Short % of Float | 0.77% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | n/a |
| Book Value Per Share | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -$31.45 million and capital expenditures -$85,000, giving a free cash flow of -$31.54 million.
| Operating Cash Flow | -31.45M |
| Capital Expenditures | -85,000 |
| Depreciation & Amortization | 919,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -31.54M |
| FCF Per Share | -$16.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 8.42% |
| Shareholder Yield | 8.42% |
| Earnings Yield | n/a |
| FCF Yield | -263.82% |
Analyst Forecast
The average price target for BOLT is $41.00, which is 574.34% higher than the current price. The consensus rating is "Buy".
| Price Target | $41.00 |
| Price Target Difference | 574.34% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 1.98% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |